Publications

human papillomavirus negative but dyskaryotic cervical cytology: re-analysis of molecular testing.	evaluation of molecular human papillomavirus (hpv) testing into uk cervical screening programmes is underway. in south wales the current hpv prevalence in women attending routine screening is 13.5% with 76.3% hr hpv positive in cases with reported dyskaryotic cervical cytology [hibbitts s, jones j, powell n, dallimore n, mcrea j, beer h, et al. human papillomavirus prevalence in women attending routine cervical screening in south wales, uk: a cross-sectional study. br j cancer 2008;99(december ( ...	2009	19264544
the potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers.	the aim of this study was to determine the proportion of invasive cervical cancers attributable to human papillomavirus (hpv) types 16 and 18 in a contemporary, cytologically well-screened uk population. this was achieved in a retrospective observational analysis by hpv typing 453 archival invasive cervical cancers diagnosed between january 1, 2000 and september 1, 2006. pathological material was collected from 9 hospitals across wales (uk), and hpv typing and pathology review was conducted at a ...	2009	19585507
prevalence of abnormalities influences cytologists' error rates in screening for cervical cancer.	medical screening tasks are often difficult, visual searches with low target prevalence (low rates of disease). under laboratory conditions, when targets are rare, nonexpert searchers show decreases in false-positive results and increases in false-negative results compared with results when targets are common. this prevalence effect is not due to vigilance failures or target unfamiliarity.	2011	22129183